Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06100965
Reduced-dose Alemtuzumab for Kidney Transplant Rejection
Sponsor: Erasmus Medical Center
View on ClinicalTrials.gov
Summary
Prospective, follow-up study of kidney transplant recipients treated with alemtuzumab anti-rejection therapy for severe or glucocorticoid-resistant kidney transplant rejection.
Official title: The Effects of Reduced Dose Alemtuzumab for Severe Kidney Transplant Rejection
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2023-12-01
Completion Date
2026-07-01
Last Updated
2024-02-21
Healthy Volunteers
No
Conditions
Locations (1)
Erasmus MC
Rotterdam, South Holland, Netherlands